INNOTEST® HIV Antigen mAb
Detects the p24 antigen of all known HIV strains.
INNOTEST HIV Antigen mAb is an enzyme immunoassay for the qualitative detection of HIV p24 antigen in human serum, plasma, and cell culture supernatant.
Product number 80563
Click here to navigate
- Contact sales for information
- Details
- Conditions of sale
- Documentation
- Insights
- FAQ
- Related products
- Product inquiry
-
Details
Features & Benefits
User-friendly assay:
- High sensitivity: 10 pg/mL in serum
- Optimal specificity: 99.9% (after retesting)
- Detects all known HIV strains
- Low sample volume: 100µL
- Results in just 2 hours
- Neutralization reagents available (Article no. 80565; CE; 2 vials).
The INNOTEST HIV Antigen mAb Neutralization Reagents kit contains reagents for confirmation of HIV p24 antigens in repeatedly reactive samples.
Additional protocols (available upon request)- Protocol for working with cell culture supernatants*
- Protocol for making Ag/Ab dissociation reagents*
- Protocol for RUO quantification of p24 antigen*
* For research use only. Not for use in diagnostics procedures.
BackgroundThe human immunodeficiency virus (HIV) is recognized as the etiological agent of acquired immune deficiency syndrome (AIDS). The virus is mainly transmitted by sexual contact, mother-to-child transmission, use of contaminated injection needles, and transfusion of contaminated blood. HIV/AIDS is one of the most important global illnesses.
According to figures published in the UNAIDS/WHO 2006 AIDS Epidemic Update, an estimated 39.5 million people are living with HIV. There were 4.3 million new infections in 2006 with 2.8 million (65%) of these occurring in sub-Saharan Africa and important increases in Eastern Europe and Central Asia, where there are some indications that infection rates have risen by more than 50% since 2004. In 2006, 2.9 million people died of AIDS-related illnesses.
One of the major steps in restricting the spread of the disease is to inform people about their HIV status. In the industrialized world 25% do not know they are infected with the virus, and in the developing world this figure is almost 90%.
Two different causative HIV viruses have been identified: HIV-1 and HIV-2. In addition, two broad strains within the HIV-1 family have been isolated, and designated as group M (for major) and group O (for ‘outlier’). Group M can be further divided into several subtypes, responsible for most HIV infections worldwide. As the transmission rate is much higher at the beginning of infection, it is important to detect HIV infection as early as possible.
Antigen testingThe core region is the most conserved part of the different HIV strains. The INNOTEST HIV Antigen mAb test, with its carefully selected antibodies to HIV-1 core antigen p24, will also detect the cross-reacting core antigen of the other types (HIV-2 and HIV-1 group O). The INNOTEST HIV Antigen mAb test can also be of value in the detection of HIV viral antigen in tissue culture.
-
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all regulatory documentation right away.
Other documents
Filearticle_list_innotesthiv_0.pdf (pdf, 68.72 kb)Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
Insights
May 21, 2019 -
FAQ
How does the coronavirus disease Covid-19 impact Fujirebio's operations?Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
-
Related products
-
Product inquiry